7.19
price down icon2.44%   -0.18
 
loading
Exagen Inc stock is traded at $7.19, with a volume of 129.07K. It is down -2.44% in the last 24 hours and up +15.04% over the past month. Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
See More
Previous Close:
$7.37
Open:
$7.46
24h Volume:
129.07K
Relative Volume:
0.65
Market Cap:
$153.51M
Revenue:
$52.55M
Net Income/Loss:
$-23.69M
P/E Ratio:
-7.6489
EPS:
-0.94
Net Cash Flow:
$-15.29M
1W Performance:
+3.01%
1M Performance:
+15.04%
6M Performance:
+62.67%
1Y Performance:
+250.73%
1-Day Range:
Value
$7.1301
$7.495
1-Week Range:
Value
$6.51
$7.56
52-Week Range:
Value
$1.71
$7.56

Exagen Inc Stock (XGN) Company Profile

Name
Name
Exagen Inc
Name
Phone
(760) 560-1501
Name
Address
1261 LIBERTY WAY, VISTA, CA
Name
Employee
209
Name
Twitter
@ExagenInc
Name
Next Earnings Date
2025-03-11
Name
Latest SEC Filings
Name
XGN's Discussions on Twitter

Compare XGN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
XGN
Exagen Inc
7.19 152.55M 52.55M -23.69M -15.29M -0.94
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
398.36 152.41B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
192.15 136.31B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
522.21 41.46B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
113.94 32.18B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
147.37 24.40B 15.50B 1.33B 2.16B 7.34

Exagen Inc Stock (XGN) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-05-22 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Oct-15-21 Resumed Cowen Outperform
Apr-15-21 Initiated Canaccord Genuity Buy
Nov-10-20 Initiated KeyBanc Capital Markets Overweight
Oct-08-20 Initiated BTIG Research Buy
Jun-02-20 Resumed Cantor Fitzgerald Overweight
Oct-14-19 Initiated Cantor Fitzgerald Overweight
Oct-14-19 Initiated Cowen Outperform
Oct-14-19 Initiated William Blair Outperform
View All

Exagen Inc Stock (XGN) Latest News

pulisher
Jun 05, 2025

Northern Trust Corp Has $75,000 Position in Exagen Inc. (NASDAQ:XGN) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

XGN Set to Participate in Virtual Meeting on June 11 | XGN Stock News - GuruFocus

Jun 04, 2025
pulisher
May 31, 2025

Exagen Inc. (NASDAQ:XGN) Short Interest Update - Defense World

May 31, 2025
pulisher
May 30, 2025

Exagen stock soars to 52-week high, hits $7.2 amid robust gains By Investing.com - Investing.com South Africa

May 30, 2025
pulisher
May 29, 2025

Exagen stock soars to 52-week high, hits $7.2 amid robust gains - Investing.com Nigeria

May 29, 2025
pulisher
May 19, 2025

Research Analysts Issue Forecasts for Exagen FY2025 Earnings - Defense World

May 19, 2025
pulisher
May 18, 2025

Exagen Inc.'s (NASDAQ:XGN) Shares Bounce 34% But Its Business Still Trails The Industry - simplywall.st

May 18, 2025
pulisher
May 17, 2025

Cantor Fitzgerald Issues Pessimistic Forecast for Exagen (NASDAQ:XGN) Stock Price - Defense World

May 17, 2025
pulisher
May 16, 2025

Cantor Fitzgerald Reaffirms Their Buy Rating on Exagen (XGN) - The Globe and Mail

May 16, 2025
pulisher
May 15, 2025

Exagen (XGN) Target Price Adjusted by Cantor Fitzgerald Followin - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Exagen (XGN) Price Target Lowered by Cantor Fitzgerald, Rating Maintained | XGN Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Cantor Fitzgerald cuts Exagen stock target to $7, maintains Overweight By Investing.com - Investing.com Canada

May 15, 2025
pulisher
May 15, 2025

Cantor Fitzgerald cuts Exagen stock target to $7, maintains Overweight - Investing.com

May 15, 2025
pulisher
May 15, 2025

Canaccord Genuity Group Forecasts Strong Price Appreciation for Exagen (NASDAQ:XGN) Stock - Defense World

May 15, 2025
pulisher
May 13, 2025

Exagen (XGN) Maintains 'Buy' Rating as Price Target Rises | XGN Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Exagen (XGN) Receives Increased Price Target from Canaccord | XG - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Exagen (XGN) Receives Increased Price Target from Canaccord | XGN Stock News - GuruFocus

May 13, 2025
pulisher
May 13, 2025

Exagen prices public offering of common stock - MSN

May 13, 2025
pulisher
May 11, 2025

Exagen Inc. (NASDAQ:XGN) Q1 2025 Earnings Call Transcript - Insider Monkey

May 11, 2025
pulisher
May 10, 2025

Exagen Inc. Announces Closing of $20.2 Million Public Offering I - GuruFocus

May 10, 2025
pulisher
May 10, 2025

Exagen Inc. Announces Closing of $20.2 Million Public - GlobeNewswire

May 10, 2025
pulisher
May 10, 2025

Exagen Inc. anticipates $65M revenue for 2025 amid ASP growth and new biomarker launches - MSN

May 10, 2025
pulisher
May 09, 2025

Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares | XGN Stock News - GuruFocus

May 09, 2025
pulisher
May 09, 2025

Exagen Inc. Completes Additional Public Offering of 502,500 Shares, Raising Approximately $20.2 Million - Nasdaq

May 09, 2025
pulisher
May 09, 2025

Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of ... - Bluefield Daily Telegraph

May 09, 2025
pulisher
May 09, 2025

Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares - Stock Titan

May 09, 2025
pulisher
May 09, 2025

Earnings Update: Here's Why Analysts Just Lifted Their Exagen Inc. (NASDAQ:XGN) Price Target To US$7.75 - simplywall.st

May 09, 2025
pulisher
May 09, 2025

Exagen Inc (XGN)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX

May 09, 2025
pulisher
May 09, 2025

Exagen sets price for public stock offering at $5.25 per share - Investing.com Nigeria

May 09, 2025
pulisher
May 09, 2025

William Blair Issues Pessimistic Outlook for Exagen Earnings - Defense World

May 09, 2025
pulisher
May 09, 2025

Exagen prices 3.35M shares at $5.25 per share in public offering - TipRanks

May 09, 2025
pulisher
May 08, 2025

Exagen Prices $17.6 Million Public Offering; Shares Down - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Exagen Inc. Prices Public Offering Of Common Stock At $5.25 Per Share - marketscreener.com

May 08, 2025
pulisher
May 08, 2025

Exagen (XGN) Sets Price for Public Offering of Common Shares | XGN Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Exagen First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Exagen Inc. Prices Public Offering of Common Stock | XGN Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Exagen Inc. Prices Public Offering of Common Stock - Bluefield Daily Telegraph

May 08, 2025
pulisher
May 08, 2025

William Blair Estimates Exagen’s Q1 Earnings (NASDAQ:XGN) - Defense World

May 08, 2025
pulisher
May 08, 2025

Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 08, 2025
pulisher
May 07, 2025

Exagen announces common stock offering, no amount given - TipRanks

May 07, 2025
pulisher
May 07, 2025

Exagen (XGN) Announces Public Offering of Common Stock | XGN Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Exagen Inc. Announces Proposed Public Offering of Common Stock - The Manila Times

May 07, 2025
pulisher
May 07, 2025

Exagen price target raised to $9 from $5 at BTIG - TipRanks

May 07, 2025

Exagen Inc Stock (XGN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Exagen Inc Stock (XGN) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
NMSIC Co-Investment Fund, L.P.
10% Owner
Nov 20 '24
Sale
3.30
200,000
660,040
2,108,958
Black Jeffrey G.
Chief Financial Officer
Nov 15 '24
Buy
2.98
22,298
66,448
274,492
ABALLI JOHN
President and CEO
Nov 14 '24
Buy
2.81
24,305
68,297
689,799
diagnostics_research DGX
$173.65
price down icon 0.09%
diagnostics_research WAT
$346.33
price down icon 1.93%
diagnostics_research LH
$252.15
price down icon 0.87%
$165.51
price down icon 1.02%
diagnostics_research MTD
$1,164.61
price down icon 0.43%
diagnostics_research IQV
$147.37
price down icon 0.36%
Cap:     |  Volume (24h):